• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子(PAF)对实验性心律失常的影响及其受影响花生四烯酸代谢产物的物质的抑制作用。

The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites.

作者信息

Riedel A, Mest H J

出版信息

Prostaglandins Leukot Med. 1987 Jun;28(1):103-9. doi: 10.1016/0262-1746(87)90051-5.

DOI:10.1016/0262-1746(87)90051-5
PMID:3112804
Abstract

Platelet-activating factor (PAF), 10(-11) mol decreased the threshold of ouabain induced arrhythmia in guinea-pigs. The thresholds inducing premature ventricular beats and ventricular flutter were statistically significantly decreased by 27.4% and 15.6%, respectively. BM 13.177 (30 mg/kg), a thromboxane receptor antagonizing substance, and esculetin (1.2 mg/kg), a lipoxygenase inhibitor, abolished this arrhythmogenic effect of PAF. Acetylsalicylic acid (10 mg/kg) showed only a tendency to inhibit the PAF effect. These results suggest that PAF could play a role in cardiac arrhythmias under special conditions and it supports the hypothesis that PAF action is mediated by the release of leukotrienes and thromboxane.

摘要

血小板活化因子(PAF),10⁻¹¹摩尔可降低豚鼠哇巴因诱发心律失常的阈值。诱发室性早搏和室性扑动的阈值分别在统计学上显著降低了27.4%和15.6%。血栓素受体拮抗物质BM 13.177(30毫克/千克)和脂氧合酶抑制剂七叶亭(1.2毫克/千克)消除了PAF的这种致心律失常作用。乙酰水杨酸(10毫克/千克)仅表现出抑制PAF作用的趋势。这些结果表明,PAF可能在特殊情况下的心律失常中起作用,并且支持PAF作用是由白三烯和血栓素的释放介导的这一假说。

相似文献

1
The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites.血小板活化因子(PAF)对实验性心律失常的影响及其受影响花生四烯酸代谢产物的物质的抑制作用。
Prostaglandins Leukot Med. 1987 Jun;28(1):103-9. doi: 10.1016/0262-1746(87)90051-5.
2
The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids.血小板活化因子(PAF)的致心律失常作用可被PAF拮抗剂以及影响类花生酸的物质所抑制。
Biomed Biochim Acta. 1988;47(10-11):S219-23.
3
The effect of substances influencing the arachidonic acid cascade on experimental cardiac arrhythmias.影响花生四烯酸级联反应的物质对实验性心律失常的作用。
Biomed Biochim Acta. 1988;47(10-11):S27-30.
4
Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias.达美格雷对哇巴因诱导的心律失常的PAF电位的保护作用。
Eur J Pharmacol. 1991 Dec 10;209(1-2):105-7. doi: 10.1016/0014-2999(91)90018-l.
5
Antagonists of PAF and histamine inhibit ouabain-induced cardiac arrhythmias in sensitized guinea-pigs.血小板活化因子(PAF)和组胺的拮抗剂可抑制致敏豚鼠中哇巴因诱导的心律失常。
Pol J Pharmacol Pharm. 1990 May-Jun;42(3):283-9.
6
WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity.WEB 2086,一种新型特异性血小板活化因子拮抗剂,可预防血小板活化因子诱导的致心律失常作用。
Pharmacol Res. 1990 Jul-Aug;22(4):445-53. doi: 10.1016/1043-6618(90)90751-x.
7
The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity.
Pharmacol Res Commun. 1987 Oct;19(10):703-12. doi: 10.1016/0031-6989(87)90100-7.
8
Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances.类二十烷酸在心脏节律紊乱生化调节中的相关性。
Biomed Biochim Acta. 1987;46(8-9):S534-8.
9
Pharmacological modulation of platelet activating factor (PAF)-induced bronchoconstriction and hypertension in anaesthetized guinea-pigs.血小板活化因子(PAF)诱导的麻醉豚鼠支气管收缩和高血压的药理学调节
J Pharm Pharmacol. 1988 Aug;40(8):544-7. doi: 10.1111/j.2042-7158.1988.tb05299.x.
10
The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.血小板激活因子从豚鼠肺中释放血栓素A2不依赖血小板,其机制与白三烯不同。
Br J Pharmacol. 1984 Jul;82(3):565-75. doi: 10.1111/j.1476-5381.1984.tb10795.x.

引用本文的文献

1
Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.心力衰竭中的血小板活化因子:在疾病进展中的潜在作用及新的治疗靶点
Curr Heart Fail Rep. 2013 Jun;10(2):122-9. doi: 10.1007/s11897-013-0131-2.